ADP / Zander SA / Proc Natl Acad Sci U S A / Julie Sawitzke Laboratory / /
Country
United States / / /
Event
FDA Phase / /
Facility
National Cancer Institute / Hall MJ / Julie Sawitzke Laboratory of Experimental Immunology / /
IndustryTerm
cancer therapy / internal program audit / breast cancer therapy / /
MarketIndex
SET 50 / /
MedicalCondition
prostrate and pancreatic cancers / cancers / tumor / PROJECT AIMS Breast cancer / high risk breast cancer / breast cancers / common cancer / cancer / JE / relatively few breast cancer / tumors / disease / ER/PR positive tumors / aggressive breast cancers / triple negative tumors / triple negative disease / negative disease / breast and ovarian cancer / triple negative breast cancer / high grade prostate cancer / BMC Cancer / ovarian and prostate cancer / stable disease / hereditary breast ovarian cancer / BRCA1 deficient mammary tumors / breast cancer / basal type/triple negative disease / testing for hereditary breast ovarian cancer / /
MedicalTreatment
breast cancer therapy / chemotherapy / cancer therapy / /
Organization
National Cancer Institute / American Cancer Society Avon Foundation / Department of Health and Human Services / Howard University / Center for Cancer Research / /
Person
Michael Dean / Latoya Silverton / Ann Oncol / Lorenzo Bermejo / Frederick / / /
Position
PRINCIPAL INVESTIGATOR / Cao / Secretary / Pilarski RT / /
Nationwide Study of Breast Cancer Risk Factors in Latinas Michael Dean, Latoya Silverton, Julie Sawitzke Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute